Targeting Antimalarial Metabolites from the Actinomycetes Associated with the Red Sea Sponge Callyspongia Siphonella Using a Metabolomic Method

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2023 Dec 12

PMID 38087203

Authors

Noha M Gamaleldin

Hebatallah S Bahr

Natalie Millan-Aguinaga

Mahshid Danesh

Eman M Othman

Thomas Dandekar

Hossam M Hassan

Usama Ramadan Abdelmohsen

Affiliations

Soon will be listed here.

Abstract

Malaria is a persistent illness that is still a public health issue. On the other hand, marine organisms are considered a rich source of anti‑infective drugs and other medically significant compounds. Herein, we reported the isolation of the actinomycete associated with the Red Sea sponge Callyspongia siphonella. Using "one strain many compounds" (OSMAC) approach, a suitable strain was identified and then sub-cultured in three different media (M1, ISP2 and OLIGO). The extracts were evaluated for their in-vitro antimalarial activity against Plasmodium falciparum strain and subsequently analyzed by Liquid chromatography coupled with high-resolution mass spectrometry (LC-HR-MS). In addition, MetaboAnalyst 5.0 was used to statistically analyze the LC-MS data. Finally, Molecular docking was carried out for the dereplicated metabolites against lysyl-tRNA synthetase (PfKRS1). The phylogenetic study of the 16S rRNA sequence of the actinomycete isolate revealed its affiliation to Streptomyces genus. Antimalarial screening revealed that ISP2 media is the most active against Plasmodium falciparum strain. Based on LC-HR-MS based metabolomics and multivariate analyses, the static cultures of the media, ISP2 (ISP2-S) and M1 (M1-S), are the optimal media for metabolites production. OPLS-DA suggested that quinone derivatives are abundant in the extracts with the highest antimalarial activity. Fifteen compounds were identified where eight of these metabolites were correlated to the observed antimalarial activity of the active extracts. According to molecular docking experiments, saframycin Y3 and juglomycin E showed the greatest binding energy scores (-6.2 and -5.13) to lysyl-tRNA synthetase (PfKRS1), respectively. Using metabolomics and molecular docking investigation, the quinones, saframycin Y3 (5) and juglomycin E (1) were identified as promising antimalarial therapeutic candidates. Our approach can be used as a first evaluation stage in natural product drug development, facilitating the separation of chosen metabolites, particularly biologically active ones.

References

Abdelmohsen U, Yang C, Horn H, Hajjar D, Ravasi T, Hentschel U . Actinomycetes from Red Sea sponges: sources for chemical and phylogenetic diversity. Mar Drugs. 2014; 12(5):2771-89. PMC: 4052315. DOI: 10.3390/md12052771. View

Wang J, Zhang H, Yang X, Zhou Y, Wang H, Bai H . HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071. J Antibiot (Tokyo). 2009; 61(10):623-6. DOI: 10.1038/ja.2008.82. View

Letunic I, Bork P . Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2006; 23(1):127-8. DOI: 10.1093/bioinformatics/btl529. View

Kunz A, Labes A, Wiese J, Bruhn T, Bringmann G, Imhoff J . Nature's lab for derivatization: new and revised structures of a variety of streptophenazines produced by a sponge-derived Streptomyces strain. Mar Drugs. 2014; 12(4):1699-714. PMC: 4012441. DOI: 10.3390/md12041699. View

Khan S, Garg A, Camacho N, van Rooyen J, Kumar Pole A, Belrhali H . Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development. Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 5):785-95. DOI: 10.1107/S0907444913001923. View

El-Hawary S, Mohammed R, Bahr H, Attia E, El-Katatny M, Abelyan N . Soybean-associated endophytic fungi as potential source for anti-COVID-19 metabolites supported by docking analysis. J Appl Microbiol. 2021; 131(3):1193-1211. PMC: 8013715. DOI: 10.1111/jam.15031. View

Abdelmohsen U, Grkovic T, Balasubramanian S, Kamel M, Quinn R, Hentschel U . Elicitation of secondary metabolism in actinomycetes. Biotechnol Adv. 2015; 33(6 Pt 1):798-811. DOI: 10.1016/j.biotechadv.2015.06.003. View

Hanwell M, Curtis D, Lonie D, Vandermeersch T, Zurek E, Hutchison G . Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012; 4(1):17. PMC: 3542060. DOI: 10.1186/1758-2946-4-17. View

El-Hawary S, Sayed A, Mohammed R, Hassan H, Rateb M, Amin E . Bioactive Brominated Oxindole Alkaloids from the Red Sea Sponge . Mar Drugs. 2019; 17(8). PMC: 6723499. DOI: 10.3390/md17080465. View

10.

Corre C, Song L, ORourke S, Chater K, Challis G . 2-Alkyl-4-hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by Streptomyces coelicolor genome mining. Proc Natl Acad Sci U S A. 2008; 105(45):17510-5. PMC: 2582273. DOI: 10.1073/pnas.0805530105. View

11.

Yazawa K, Takahashi K, Mikami Y, Arai T, Saito N, Kubo A . Isolation and structural elucidation of new saframycins Y3, Yd-1, Yd-2, Ad-1, Y2b and Y2b-d. J Antibiot (Tokyo). 1986; 39(12):1639-50. DOI: 10.7164/antibiotics.39.1639. View

12.

Stecher G, Tamura K, Kumar S . Molecular Evolutionary Genetics Analysis (MEGA) for macOS. Mol Biol Evol. 2020; 37(4):1237-1239. PMC: 7086165. DOI: 10.1093/molbev/msz312. View

13.

Ashelford K, Chuzhanova N, Fry J, Jones A, Weightman A . New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras. Appl Environ Microbiol. 2006; 72(9):5734-41. PMC: 1563593. DOI: 10.1128/AEM.00556-06. View

14.

Raheem D, Tawfike A, Abdelmohsen U, Edrada-Ebel R, Fitzsimmons-Thoss V . Application of metabolomics and molecular networking in investigating the chemical profile and antitrypanosomal activity of British bluebells (Hyacinthoides non-scripta). Sci Rep. 2019; 9(1):2547. PMC: 6385288. DOI: 10.1038/s41598-019-38940-w. View

15.

Izumikawa M, Kawahara T, Hwang J, Takagi M, Shin-Ya K . JBIR-107, a new metabolite from the marine-sponge-derived actinomycete, Streptomyces tateyamensis NBRC 105047. Biosci Biotechnol Biochem. 2013; 77(3):663-5. DOI: 10.1271/bbb.120832. View

16.

El-Hawary S, Sayed A, Mohammed R, Khanfar M, Rateb M, Mohammed T . New Pim-1 Kinase Inhibitor From the Co-culture of Two Sponge-Associated Actinomycetes. Front Chem. 2018; 6:538. PMC: 6262321. DOI: 10.3389/fchem.2018.00538. View

17.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

18.

Tawfike A, Romli M, Clements C, Abbott G, Young L, Schumacher M . Isolation of anticancer and anti-trypanosome secondary metabolites from the endophytic fungus Aspergillus flocculus via bioactivity guided isolation and MS based metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2019; 1106-1107:71-83. DOI: 10.1016/j.jchromb.2018.12.032. View

19.

Uwimana A, Legrand E, Stokes B, Ndikumana J, Warsame M, Umulisa N . Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020; 26(10):1602-1608. PMC: 7541349. DOI: 10.1038/s41591-020-1005-2. View

20.

Speitling M, Nattewan P, Yazawa K, Mikami Y, Grun-Wollny I, Ritzau M . Demethyl mutactimycins, new anthracycline antibiotics from Nocardia and Streptomyces strains. J Antibiot (Tokyo). 1998; 51(8):693-8. DOI: 10.7164/antibiotics.51.693. View